SEARCH

SEARCH BY CITATION

References

  • ACKERMANN, E.J., CONDE-FRIBOES, K. & DENNIS, E.A. (1995). Inhibition of macrophage Ca2+-independent phospholipase A2 by bromoenol lactone and trifluoromethyl ketones. J. Biol. Chem., 270, 445450.
  • ALOE, L., LEON, A. & LEVI-MOLTALCINI, R. (1993). A proposed autacoid mechanism controlling mastocyte behaviour. Agents Actions, 39, C145C147.
  • BAKER, D., PRYCE, G., CROXFORD, J.L., BROWN, P., PERTWEE, R.G., MAKRIYANNIS, A., KHANOLKAR, A., LAYWARD, L., FEZZA, F., BISOGNO, T. & DI MARZO, V. (2001). Endocannabinoids control spasticity in a multiple sclerosis model. FASEB J., 15, 300302.
  • BELTRAMO, M., STELLA, N., CALIGNANO, A., LIN, S.Y., MAKRIYANNIS, A. & PIOMELLI, D. (1997). Functional role of high-affinity anandamide transport, as revealed by selective inhibition. Science, 277, 10941097.
  • BISOGNO, T., MACCARRONE, M., DE PETROCELLIS, L., JARRAHIAN, A., FINAZZI-AGRÒ, A., HILLARD, C. & DI MARZO, V. (2001). The uptake by cells of 2-arachidonoylglycerol, an endogenous agonist of cannabinoid receptors. Eur. J. Biochem., 268, 19821989.
  • BISOGNO, T., MAURELLI, S., MELCK, D., DE PETROCELLIS, L. & DI MARZO, V. (1997). Biosynthesis, uptake, and degradation of anandamide and palmitoylethanolamide in leukocytes. J. Biol. Chem., 272, 33153323.
  • BISOGNO, T., MELCK, D., DE PETROCELLIS, L., BOBROV, M.Y., GRETSKAYA, N.M., BEZUGLOV, V.V., SITACHITTA, N., GERWICK, W.H. & DI MARZO, V. (1998). Arachidonoylserotonin and other novel inhibitors of fatty acid amide hydrolase. Biochem. Biophys. Res. Commun., 248, 515522.
  • BOGER, D.L., FECIK, R.A., PATTERSON, J.E., MIYAUCHI, H., PATRICELLI, M.P. & CRAVATT, B.F. (2000a). Fatty acid amide hydrolase substrate specificity. Bioorg. Med. Chem. Lett., 10, 26132616.
  • BOGER, D.L., SATO, H., LERNER, A.E., HEDRICK, M.P., FECIK, R.A., MIYAUCHI, H., WILKIE, G.D., AUSTIN, B.J., PATRICELLI, M.P. & CRAVATT, B.F. (2000b). Exceptionally potent inhibitors of fatty acid amide hydrolase: The enzyme responsible for degradation of endogenous oleamide and anandamide. Proc. Natl. Acad. Sci. USA., 97, 50445049.
  • CALIGNANO, A., KÁTONA, I., DÉSARNAUD, F., GIUFFRIDA, A., LA RANA, G., MACKIE, K., FREUND, T.F. & PIOMELLI, D. (2000). Bidirectional control of airway responsiveness by endogenous cannabinoids. Nature, 408, 96101.
  • CALIGNANO, A., LA RANA, G., GIUFFRIDA, A. & PIOMELLI, D. (1998). Control of pain initiation by endogenous cannabinoids. Nature, 394, 277281.
  • CHILDERS, S.R., SEXTON, T. & ROY, M.B. (1994). Effects of anandamide on cannabinoid receptors in rat brain membranes. Biochem. Pharmacol., 47, 711715.
  • COMPTON, D.R. & MARTIN, B.R. (1997). The effect of the enzyme inhibitor phenylmethylsulfonyl fluoride on the pharmacological effect of anandamide in the mouse model of cannabimimetic activity. J. Pharmacol. Exp. Ther., 283, 11381143.
  • CRAVATT, B.F., GIANG, D.K., MAYFIELD, S.P., BOGER, D.L., LERNER, R.A. & GILULA, N.B. (1996). Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature, 384, 8387.
  • DE PETROCELLIS, L., BISOGNO, T., DAVIS, J.B., PERTWEE, R.G. & DI MARZO, V. (2000). Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: inhibitors of anandamide uptake with negligible capsaicin-like activity. FEBS Lett., 483, 5256.
  • DE PETROCELLIS, L., MELCK, D., PALMISANO, A., BISOGNO, T., LAEZZA, C., BIFULCO, M. & DI MARZO, V. (1998). The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation. Proc. Natl. Acad. Sci. U.S.A., 95, 83758380.
  • DEUTSCH, D.G. & CHIN, S.A. (1993). Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist. Biochem. Pharmacol., 46, 791796.
  • DEUTSCH, D.G., GLASER, S.T., HOWELL, J.M., KUNZ, J.S., PUFFENBARGER, R.A., HILLARD, C.J. & ABUMRAD, N. (2001). The cellular uptake of anandamide is coupled to its breakdown by fatty acid amide hydrolase (FAAH). J. Biol. Chem., 276, 69676973.
  • DEUTSCH, D.G., LIN, S., HILL, W.A., MORSE, K.L., SALEHANI, D., ARREAZA, G., OMEIR, R.L. & MAKRIYANNIS, A. (1997). Fatty acid sulfonyl fluorides inhibit anandamide metabolism and bind to the cannabinoid receptor. Biochem. Biophys. Res. Commun., 231, 217221.
  • DI MARZO, V., FONTANA, A., CADAS, H., SCHINELLI, S., CIMINO, G., SCHWARTZ, J.C. & PIOMELLI, D. (1994). Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature, 372, 686691.
  • EISENTHAL, R. & CORNISH-BOWDEN, A. (1974). The direct linear plot. A new graphical procedure for estimating enzyme kinetic parameters. Biochem. J., 139, 715720.
  • FELDER, C.C., BRILEY, E.M., AXELROD, J., SIMPSON, J.T., MACKIE, K. & DEVANE, W.A. (1993). Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor-mediated signal transduction. Proc. Natl. Acad. Sci. U.S.A., 90, 76567660.
  • FOWLER, C.J., TIGER, G. & STENSTRÖM, A. (1997). Ibuprofen inhibits rat brain deamidation of anandamide at pharmacologically relevant concentrations. Mode of inhibition and structure-activity relationship. J. Pharmacol. Exp. Ther., 283, 729734.
  • FOWLER, C.J., BÖRJESSON, M. & TIGER, G. (2000). Differences in the pharmacological properties of rat and chicken brain fatty acid amidohydrolase. Br. J. Pharmacol., 131, 498504.
  • GAULDIE, S.D., MCQUEEN, D.S., PERTWEE, R. & CHESSELL, I.P. (2001). Anandamide activates peripheral nociceptors in normal and arthritic knee joints. Br. J. Pharmacol., 132, 617621.
  • GIFFORD, A.N., BRUNEUS, M., LIN, S., GOUTOPOULOS, A., MAKRIYANNIS, A., VOLKOW, N.D. & GATLEY, S.J. (1999). Potentiation of the action of anandamide on hippocampal slices by the fatty acid amide hydrolase inhibitor, palmitylsulphonyl fluoride (AM 374). Eur. J. Pharmacol., 383, 914.
  • GIUFFRIDA, A., RODRIGUEZ DE FONSECA, F., NAVA, F., LOUBET-LESCOULIÉ, P. & PIOMELLI, D. (2000). Elevated circulating levels of anandamide after administration of the transport inhibitor, AM404. Eur. J. Pharmacol., 408, 161168.
  • HARRINGTON, C.R. (1990). Lowry protein assay containing sodium dodecyl sulfate in microtiter plates for protein determination on fractions from brain tissue. Analyt. Biochem., 186, 285287.
  • HILLARD, C.J., EDGEMOND, W.S., JARRAHIAN, A. & CAMPBELL, W.B. (1997). Accumulation of N-arachidonoylethanolamine (anandamide) into cerebellar granule cells occurs via facilitated diffusion. J. Neurochem., 69, 631638.
  • JACOBSSON, S.O.P. & FOWLER, C.J. (2001). Characterization of palmitoylethanolamide transport in mouse Neuro-2a neuroblastoma and rat RBL-2H3 basophilic leukaemia cells: comparison with anandamide. Br. J. Pharmacol., 132, 17431754.
  • JAGGAR, S.I., HASNIE, F.S., SELLATURAY, S. & RICE, A.S.C. (1998). The anti-hyperalgesic actions of the cannabinoid anandamide and the putative CB2 receptor agonist palmitoylethanolamide in visceral and somatic inflammatory pain. Pain, 76, 189199.
  • JARRAHIAN, A., MANNA, S., EDGEMOND, W.S., CAMPBELL, W.B. & HILLARD, C.J. (2000). Structure-activity relationships among N-arachidonoylethanolamine (anandamide) head group analogues for the anandamide transporter. J. Neurochem., 74, 25972606.
  • KOUTEK, B., PRESTWICH, G.D., HOWLETT, A.C., CHIN, S.A., SALEHANI, D., AKHAVAN, N. & DEUTSCH, D.G. (1994). Inhibitors of arachidonoyl ethanolamide hydrolysis. J. Biol. Chem., 269, 2293722940.
  • LAMBERT, D.M. & DI MARZO, V. (1999). The palmitoylethanolamide and oleamide enigmas: are these two fatty acid amides cannabimimetic Curr. Med. Chem., 6, 757773.
  • LAMBERT, D.M., DIPAOLO, F.G., SONVEAUX, P., KANYONYO, M., GOVAERTS, S.J., HERMANS, E., BUEB, J., DELZENNE, N.M. & TSCHIRHART, E.J. (1999). Analogues and homologues of N-palmitoylethanolamide, a putative endogenous CB2 cannabinoid, as potential ligands for the cannabinoid receptors. Biochim. Biophys. Acta, 1440, 266274.
  • LANG, W., QIN, C., LIN, S., KHANOLKAR, A.D., GOUTOPOULOS, A., FAN, P., ABOUZID, K., MENG, Z., BIEGEL, D. & MAKRIYANNIS, A. (1999). Substrate specificity and stereoselectivity of rat brain microsomal anandamide amidohydrolase. J. Med. Chem., 42, 896902.
  • MACCARRONE, M., LORENZON, T., BARI, M., MELINO, G. & FINAZZI-AGRÒ, A. (2000). Anandamide induces apoptosis in human cells via vanilloid receptors. Evidence for a protective role of cannabinoid receptors. J. Biol. Chem., 275, 3193831945.
  • MALLET, P.E. & BENINGER, R.J. (1998). The cannabinoid CB1 receptor antagonist SR 141716A attenuates the memory impairment produced by Δ9-tetrahydro-cannabinol or anandamide. Psychopharmacology, 140, 1119.
  • MAURELLI, S., BISOGNO, T., DE PETROCELLIS, L., DI LUCCIA, A., MARINO, G. & DI MARZO, V. (1995). Two novel classes of neuroactive fatty acid amides are substrates for mouse neuroblastoma ‘anandamide amidohydrolase’. FEBS Letts., 377, 8286.
  • MAZZARI, S., CANELLA, R., PETRELLI, L., MARCOLONGO, G. & LEON, A. (1996). N-(2-hydroxyethyl)hexadecamide is orally active in reducing edema formation and inflammatory hyperalgesia by down-modulating mast cell activation. Eur. J. Pharmacol., 300, 227236.
  • MECHOULAM, R., FRIDE, E. & DI MARZO, V. (1998). Endocannabinoids. Eur. J. Pharmacol., 359, 118.
  • MELCK, D., BISOGNO, T., DE PETROCELLIS, L., CHUANG, H.H., JULIUS, D., BIFULCO, M. & DI MARZO, V. (1999). Unsaturated long-chain N-acyl-vanillyl-amides (N-AVAMs): vanilloid receptor ligands that inhibit anandamide-facilitated transport and bind to CB1 cannabinoid receptors. Biochem. Biophys. Res. Commun., 262, 275284.
  • NATARAJAN, V., SCHMID, P.C., REDDY, P.V. & SCHMID, H.H.O. (1984). Catabolism of N-acylethanolamine phospholipids by dog brain preparations. J. Neurochem., 42, 16131619.
  • OMEIR, R.L., CHIN, S., HONG, Y., AHERN, D.G. & DEUTSCH, D.G. (1995). Arachidonoyl ethanolamide-[1,2-14C] as a substrate for anandamide amidase. Life Sci., 56, 19992005.
  • PATTERSON, J.E., OLLMANN, I.R., CRAVATT, B.F., BOGER, D.L., WONG, C.-H. & LERNER, R.A. (1996). Inhibition of oleamide hydrolase catalyzed hydrolysis of the endogenous sleep-inducing lipid cis-9-octadecenamide. J. Am. Chem. Soc., 118, 59385945.
  • PERTWEE, R.G., FERNANDO, S.R., GRIFFIN, G., ABADJI, V. & MAKRIYANNIS, A. (1995). Effect of phenylmethylsulphonyl fluoride on the potency of anandamide as an inhibitor of electrically evoked contractions in two isolated tissue preparations. Eur. J. Pharmacol., 272, 7378.
  • PIOMELLI, D., GIUFFRUDA, A., CALIGNANO, A., DE FONSECA, F.R. (2000). The endocannabinoid system as a target for therapeutic drugs. Trends Pharmacol. Sci., 21, 218224.
  • RAFFA, R.B., STONE, D.J. & HIPP, S.J. (1999). Differential cholera-toxin sensitivity of supraspinal antinociception induced by the cannabinoid agonist Δ9-THC, WIN 55,212-2 and anandamide in mice. Neuroscience Letts., 263, 2932.
  • RAKHSHAN, F., DAY, T.A., BLAKELY, R.D. & BARKER, E.L. (2000). Carrier-mediated uptake of the endogenous cannabinoid anandamide in RBL-2H3 cells. J. Pharmacol. Exp. Ther., 292, 960967.
  • RICHARDSON, J.D., KILO, S. & HARGREAVES, K.M. (1998). Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB1 receptors. Pain, 75, 111119.
  • ROSS, R.A., MURPHY, V.L., MCKAY, N.G., ASHFORD, M.L.J. & PERTWEE, R.G. (1999). Characterization of cannabinoid receptors in the spleen and in mast cells. In Essential Fatty Acids and Eicosanoids: Invited papers from the 4th International Congress. ed. Riemersma, R.A., Armstrong, R., Kelly, R.W. & Wilson, R. pp. 376379. Champaign, IL, USA, AOCS Press.
  • SARKER, K.P., OBARA, S., NAKATA, M., KITAJIMA, I. & MARUYAMA, I. (2000). Anandamide induces apoptosis of PC-12 cells: involvement of superoxide and caspase-3. FEBS Letts., 472, 3944.
  • SCHMID, P.C., ZUZARTE-AUGUSTIN, M.L. & SCHMID, H.H.O. (1985). Properties of rat liver N-acylethanolamine amidohydrolase. J. Biol. Chem., 260, 1414514149.
  • SUGIURA, T., KONDO, S., KISHIMOTO, S., MIYASHITA, T., NAKANE, S., KODAKA, T., SUHARA, Y., TAKAYAMA, H. & WAKU, K. (2000). Evidence that 2-arachidonoylglycerol but not N-palmitoylethanolamide or anandamide is the physiological ligand for the cannabinoid CB2 receptor. Comparison of the agonistic activities of various cannabinoid receptor ligands in HL-60 cells. J. Biol. Chem., 275, 605612.
  • TERRANOVA, J.-P, MICHAUD, J.-C, LE FUR, G. & SOUBRIÉ, P. (1995). Inhibition of long-term potentiation in rat hippocampal slices by anandamide and WIN55212-2: reversal by SR141716 A, a selective antagonist of CB1 cannabinoid receptors. Naunyn-Schmiedebergs Arch. Pharmacol., 352, 576579.
  • TIGER, G., STENSTRÖM, A. & FOWLER, C.J. (2000). Pharmacological properties of rat brain fatty acid amidohydrolase in different subcellular fractions using palmitoylethanolamide as substrate. Biochem. Pharmacol., 59, 647653.